Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion in a move intended to expand its endocrinology and rare-disease portfolio.
Source link
Neurocrine to Buy Soleno for $2.9 Billion
Date:
More like thisRelated
Alcoa Cuts Production Guidance, Says Alumina Prices Stable Despite Iran War
Alcoa cut its full-year alumina guidance, citing issues at...
Open Championship: An unlikely leader, Bryson’s bounce-back and Rory’s struggles
Jul 16, 2026, 05:40 PM ETSOUTHPORT, England -- There...
El gol de Merino y la garra de Argentina marcaron los cuartos de final
IE 11 no es compatible. Para una experiencia óptima,...
Iceberg lettuce sold at Taco Bell linked to cyclospora outbreak
Iceberg lettuce sold at Taco Bell linked to cyclospora...